Annovis Bio (ANVS, $18.01) was one of top quarterly gainers, jumping +8 to $18.01 per share. A.I.dvisor analyzed 913 stocks in the Biotechnology Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.